Размер мирового рынка, прогноз и основные тенденции на 2023-2033 годы
The transfusion diagnostics market size is expected to reach US$ 9 billion by the end of 2033, growing at a CAGR of 4% during the forecast period, i.e., 2023–2033. The transfusion diagnostics industry size crossed US$ 4 billion in 2022. The market growth is primarily driven by the increasing number of people with impaired kidney function. Kidney failure, commonly known as chronic kidney disease (CKD), is a condition in which the kidneys are unable to adequately remove waste and excess fluid from the blood. This can lead to a variety of problems, including anemia, which is common in patients with CKD. Regular blood transfusions are often required by patients with CKD to treat anemia, as well as other problems such as bleeding, clotting, and infection. Around 850 million people suffer from some form of kidney problem. Additionally, around 121,000 people in the US require a kidney transplant.
Increasing number of injuries and deaths due to road accidents will fuel the growth of the global blood transfusion market. Road accidents are a major public health concern and a leading source of deaths and injuries worldwide. These incidents often result in serious injuries that require urgent medical attention and blood transfusion. The rising incidence of road accidents and related injuries is expected to increase the demand for blood. Around 3,700 people worldwide die every day in road accidents or after being hit by vehicles. Additionally, the rising incidence of chronic diseases worldwide and the urgent need for blood donations due to shortage of donor blood during the pandemic are the few factors that are expected to fuel the market growth.
Сектор диагностики переливания крови: движущие силы роста и проблемы
Growth Drivers
<ul>
- More People Requiring Dialysis – Dialysis is a treatment for kidney failure that filters the blood to remove unwanted toxins, waste products, and excess fluid. When the kidneys fail, the body struggles to cleanse the blood and maintain the chemical balance of the system. This is estimated to drive the blood transfusion diagnostics market growth over the forecast period. Globally, approximately 5-10 million people require dialysis or transplantation. Moreover, the prevalence of chronic kidney disease is nearly 10% in men and about 11% in women.
- Growing prevalence of chronic diseases. Chronic diseases such as cancer, cardiovascular disease, leukemia and other autoimmune diseases may require blood transfusions. According to the World Health Organization, chronic cardiovascular diseases are the leading cause of death worldwide. In addition, about 18 million people died from cardiovascular diseases.
- Need to fill the blood shortage caused by the pandemic. The blood shortage is caused by the impact of COVID-19 on the supply chain and blood donation networks. This is especially true during emergencies, as surgeries and emergency medical care often require blood. The blood transfusion diagnostics market is poised to expand as a result of the growing need for diagnostic tools and tests to detect these diseases. During COVID-19, blood donation activity has dropped from about 40% to 67%, causing a huge blood shortage worldwide, with the number of blood donors in various countries decreasing by about 20-30%.
- Increase in road traffic accidents. Road traffic accidents often result in urgent visits to the emergency department (ER), where immediate blood transfusions may be required. According to the World Health Organization, approximately 1.3 million people die in road traffic accidents every day.
Problems
- Lack of technologists to perform automated autotransfusion. Advanced systems such as nucleic acid amplification test and centrifugal machines used to separate blood cells require skilled technicians, so the lack of experienced technicians is hampering the growth of the market.
- Lack of appropriate infrastructure.
- The high cost of the instruments, tests and treatment required for blood transfusions.
Рынок диагностики переливания крови: ключевые выводы
<body> <tr> <tr> <tr> <tr> <tr> <tr>
|
Base year |
2022 |
|
Forecasted year |
2023–2033 |
|
CAGR |
~4% |
|
Market size in the base year (2022) |
~4 billion US dollars |
|
Market size for the forecast year (2033) |
~9 billion US dollars |
|
Regional coverage |
<ul>
|
Сегментация диагностики переливания крови
Application (blood group determination, blood screening)
The blood transfusion diagnostics market is segmented and analyzed for supply and demand across blood typing and blood screening applications . Of the two, the blood screening segment is expected to account for the largest market size by the end of 2033. The increase in blood donation and transfusion is likely to drive the growth of this segment. According to WHO statistics, around 119 million blood donations are made worldwide every year. Furthermore, the growth of this segment is driven by the increasing prevalence of sexually transmitted diseases, hepatitis B, and HIV. According to the Centers for Disease Control and Prevention, around 296 million people worldwide are living with hepatitis B. Moreover, according to the World Health Organization, the prevalence of STDs has affected more than 1 million people worldwide.
End user (hospital laboratories, blood banks)
The global blood transfusion diagnostics market is also segmented and analyzed for supply and demand from end users in hospital laboratories and blood banks. Of these segments, hospital laboratories are projected to hold a higher market share by 2033. This could be due to the fact that hospital laboratories are better equipped to perform the complex and critical screening procedures required for blood transfusions as they are equipped with the latest equipment and technology and are managed by skilled personnel. Additionally, these laboratories are well positioned to provide patients with various diagnostic services such as blood typing. Additionally, hospitals are expanding their diagnostic capabilities to meet the growing need for blood products as the demand for blood transfusions increases. For example, it was found that there were about 6,100 hospitals in the United States in 2022.
Our in-depth analysis of the global market includes the following segments
By product type
- Tools
- Reagents and kits
- <tr> <td>
By applications
<td> <ul> - Blood group determination
- Blood screening
- <tr> <td>
End user
<td> <ul> - Hospital-based laboratories
- Blood banks
Хотите настроить этот исследовательский отчет в соответствии с вашими требованиями? Наша исследовательская команда предоставит необходимую информацию, чтобы помочь вам принимать эффективные бизнес-решения.
Настроить этот отчетКровь Индустрия трансфузионной диагностики – региональный обзор
Asia Pacific Market Statistics
The Asia Pacific blood transfusion diagnostics market is projected to hold the largest market share among all other regions by the end of 2033. This is driven by aspects such as the growing need for blood transfusion, evolving healthcare infrastructure in the region, and increasing public awareness about the value of blood donation and testing. A significant portion of the Asia Pacific blood transfusion diagnostics market is expected to increase in countries such as China and India due to their large populations and rapidly growing healthcare infrastructure. Other countries in the region are also expected to grow due to factors such as the increasing number of hospital-based diagnostic labs and the desire for fast and accurate blood tests.
North American Market Forecast
The North American blood transfusion diagnostics market is projected to hold the largest market share among all other regions by the end of 2033. The market growth is driven by the higher number of road traffic accidents occurring in the region. in North America. As of 2022, there are more than 6 million road traffic accidents in the United States. The growth is also attributed to the blood shortage during COVID-19, which in turn increases the need for blood donations. Since March 2020, the blood donation rate has decreased by about 10%, and the number of blood donors in colleges and schools has decreased by about 62%.
Компании, доминирующие в сфере диагностики переливания крови
- Immucor, Inc.
- Company overview
- Business strategy
- Main product offerings
- Financial indicators
- Key performance indicators
- Risk analysis
- Latest developments
- Regional presence
- SWOT analysis
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- The coefficient is limited
- Beckman Coulter, Inc.
- DiaSorin SpA
- BD (Becton, Dickinson and Company)
- Orthoclinical diagnostics
- Grifols, S.A.
- Thermo Fisher Scientific Inc.
<ul>
In the News
<ul> <li>
Danaher Corporation announced the acquisition of Aldervon. Aldervon was the sole operating company in Danaher's Life Sciences segment.
<li>
Grifols SA announced the acquisition of Biotest to drive the development and innovation of its product portfolio, increasing access to plasma-based therapies for patients.
Авторы отчета: Radhika Pawar
- Report ID: 4481
- Published Date: Feb 23, 2023
- Report Format: PDF, PPT
